{{Rsnum
|rsid=6692804
|Gene=GNAI3
|Chromosome=1
|position=109566120
|Orientation=plus
|GMAF=0.3003
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|effect1=
|effect2=
|effect3=
|Gene_s=GNAI3
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 0.0 | 0.0
| HCB | 8.9 | 40.0 | 51.1
| JPT | 9.1 | 63.6 | 27.3
| YRI | 27.0 | 47.6 | 25.4
| ASW | 0.0 | 0.0 | 0.0
| CHB | 8.9 | 40.0 | 51.1
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}[[rs6692804]] was the only SNP found to be significantly (p = 0.03) associated with [[Parkinson's disease]] risk in a study of 525 patients.{{PMID|18628988|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}